GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Spectral Medical Inc (TSX:EDT) » Definitions » Gross Profit

Spectral Medical (TSX:EDT) Gross Profit : C$0.72 Mil (TTM As of Jun. 2024)


View and export this data going back to 1994. Start your Free Trial

What is Spectral Medical Gross Profit?

Spectral Medical's gross profit for the three months ended in Jun. 2024 was C$0.08 Mil. Spectral Medical's gross profit for the trailing twelve months (TTM) ended in Jun. 2024 was C$0.72 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Spectral Medical's gross profit for the three months ended in Jun. 2024 was C$0.08 Mil. Spectral Medical's Revenue for the three months ended in Jun. 2024 was C$0.47 Mil. Therefore, Spectral Medical's Gross Margin % for the quarter that ended in Jun. 2024 was 17.62%.

Spectral Medical had a gross margin of 17.62% for the quarter that ended in Jun. 2024 => No sustainable competitive advantage

During the past 13 years, the highest Gross Margin % of Spectral Medical was 90.42%. The lowest was 37.61%. And the median was 75.95%.

Warning Sign:

Spectral Medical Inc gross margin has been in long-term decline. The average rate of decline per year is -13%.


Spectral Medical Gross Profit Historical Data

The historical data trend for Spectral Medical's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Spectral Medical Gross Profit Chart

Spectral Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.22 1.47 1.21 0.98 0.66

Spectral Medical Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.09 0.15 0.39 0.08

Competitive Comparison of Spectral Medical's Gross Profit

For the Diagnostics & Research subindustry, Spectral Medical's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Spectral Medical's Gross Profit Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Spectral Medical's Gross Profit distribution charts can be found below:

* The bar in red indicates where Spectral Medical's Gross Profit falls into.



Spectral Medical Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Spectral Medical's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=1.598 - 0.936
=0.66

Spectral Medical's Gross Profit for the quarter that ended in Jun. 2024 is calculated as

Gross Profit (Q: Jun. 2024 )=Revenue - Cost of Goods Sold
=0.471 - 0.388
=0.08

Gross Profit for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.72 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Spectral Medical's Gross Margin % for the quarter that ended in Jun. 2024 is calculated as

Gross Margin % (Q: Jun. 2024 )=Gross Profit (Q: Jun. 2024 ) / Revenue (Q: Jun. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.08 / 0.471
=17.62 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Spectral Medical  (TSX:EDT) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Spectral Medical had a gross margin of 17.62% for the quarter that ended in Jun. 2024 => No sustainable competitive advantage


Spectral Medical Gross Profit Related Terms

Thank you for viewing the detailed overview of Spectral Medical's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Spectral Medical Business Description

Traded in Other Exchanges
Address
135 The West Mall, Unit 2, Finance, Toronto, ON, CAN, M9C 1C2
Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the Toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation.
Executives
Paul M. Walker Director
John Ernest Nosenzo Director
Chris Seto Senior Officer
William Charles Stevens Director
Kevin Arnold Giese Director
Gualtiero Piero Guido Maria Guadagni Senior Officer
Debra-anne Foster Deemed Insider - 6 Months before becoming Insider
Anthony Phillip Bihl Director

Spectral Medical Headlines